GILD Stock News: Continue Buying At Current Prices


  • Gilead Sciences’ stock price has increased over 50% in the last year, in most part because of the rapid growth of its HCV drugs.gild stock news
  • Sales of these drugs will not fall off, with plenty of additional growth still to be had.
  • Along with the success in the HIV market and potential in the oncology field, the company’s pipeline is currently robust.
  • With a cheap valuation and a large cash pile with which to return value to shareholders, this stock is still attractive to long-term investors.
  • I Know First algorithm is bullish on Gilead Sciences over the next year, believing the stock price will climb to new highs.

Read The Full Article Here